Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening
Jennifer L. Reid, Cristina Giachetti, Mark H. Stoler(University of Virginia), Damon Getman(Hologic (United States)), Thomas C. Wright(Columbia University), Jack Cuzick(Queen Mary University of London), Philip E. Castle(National Cancer Institute), Janel Dockter(Illumina (United States))
Cited by 56
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
Human Papillomavirus Testing in the Prevention of Cervical Cancer
|JNCI Journal of the National Cancer Institute|2011|767